| Devona Marshall, LPC | |
|
400 W River Dr, West Bend, WI 53090-1518 | |
| (262) 334-4340 | |
| (262) 334-4341 |
| Full Name | Devona Marshall |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 400 W River Dr, West Bend, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740396241 | NPI | - | NPPES |
| 40984400 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | 3514-125 (Wisconsin) | Secondary |
| 101YP2500X | Counselor - Professional | 3514-125 (Wisconsin) | Primary |
| Entity Name | Kettle Moraine Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568790954 PECOS PAC ID: 8527353747 Enrollment ID: O20200416001123 |
News Archive
CPL Biologicals (CPLB), a joint venture of Cadila Pharmaceuticals Ltd. and Novavax, Inc., today announced that it has completed construction of its vaccine facility in Dholka, India and will commence equipment and installation validation this month so that the facility conforms to global standards for production of vaccines for human use.
As demand for smaller, less intrusive medical devices continues to grow, designers and OEMs are increasingly seeking materials with properties that can make these new devices possible. Bayer MaterialScience LLC is launching a new grade of medical polycarbonate to address this need during the Medical Design & Manufacturing East conference, taking place at the Jacob K. Javits Convention Center in New York City, June 6-9.
The prevalence of adults in the U.S. who are obese is still high, with about one-third of adults obese in 2007-2008, although new data suggest that the rate of increase for obesity in the U.S. in recent decades may be slowing, according to a study appearing in the January 20 issue of JAMA.
Perrigo Company today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg.
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the New England Journal of Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Devona Marshall, LPC 400 W River Dr, West Bend, WI 53090-1518 Ph: (262) 334-4340 | Devona Marshall, LPC 400 W River Dr, West Bend, WI 53090-1518 Ph: (262) 334-4340 |
News Archive
CPL Biologicals (CPLB), a joint venture of Cadila Pharmaceuticals Ltd. and Novavax, Inc., today announced that it has completed construction of its vaccine facility in Dholka, India and will commence equipment and installation validation this month so that the facility conforms to global standards for production of vaccines for human use.
As demand for smaller, less intrusive medical devices continues to grow, designers and OEMs are increasingly seeking materials with properties that can make these new devices possible. Bayer MaterialScience LLC is launching a new grade of medical polycarbonate to address this need during the Medical Design & Manufacturing East conference, taking place at the Jacob K. Javits Convention Center in New York City, June 6-9.
The prevalence of adults in the U.S. who are obese is still high, with about one-third of adults obese in 2007-2008, although new data suggest that the rate of increase for obesity in the U.S. in recent decades may be slowing, according to a study appearing in the January 20 issue of JAMA.
Perrigo Company today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg.
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the New England Journal of Medicine.
› Verified 3 days ago
Ms. Ashley Elizabeth Birkholz, CAPSW, SAC Counselor Medicare: Accepting Medicare Assignments Practice Location: 1626 Clarence Ct, West Bend, WI 53095 Phone: 262-338-8611 Fax: 262-338-3367 | |
Renee M Janusz, CSAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 333 E Washington St Ste 2000, West Bend, WI 53095 Phone: 262-335-4545 Fax: 262-335-6827 | |
William James Skalecki, Counselor Medicare: Not Enrolled in Medicare Practice Location: 120 N Main St Ste 110, West Bend, WI 53095 Phone: 262-707-3052 | |
Jennifer Ryan, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1626 Clarence Ct, West Bend, WI 53095 Phone: 262-338-8611 | |
Jonathan France, LPC, SAC-IT Counselor Medicare: Medicare Enrolled Practice Location: 333 E Washington St Ste 2100, West Bend, WI 53095 Phone: 262-365-6563 Fax: 262-365-6559 | |
Leah Matthews, LCSW, CSAC Counselor Medicare: Accepting Medicare Assignments Practice Location: 1626 Clarence Ct, West Bend, WI 53095 Phone: 262-338-8611 | |
Hollister L Jefferson, M.A., SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 W River Dr, West Bend, WI 53090 Phone: 262-334-4340 |